Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12619001500145
Ethics application status
Approved
Date submitted
30/09/2019
Date registered
30/10/2019
Date last updated
6/05/2021
Date data sharing statement initially provided
30/10/2019
Type of registration
Prospectively registered
Titles & IDs
Public title
Effects on disease activity, self-reported symptoms and microbiota profile in patients with inflammatory bowel disease of a modified anti-inflammatory diet.
Query!
Scientific title
Effects on disease activity, self-reported symptoms and microbiota profile in patients with inflammatory bowel disease of a modified anti-inflammatory diet.
Query!
Secondary ID [1]
299448
0
Nill known
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
IBD MAID
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Inflammatory Bowel Disease
314647
0
Query!
Condition category
Condition code
Diet and Nutrition
312985
312985
0
0
Query!
Other diet and nutrition disorders
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Following the completion of screening patients will be randomized to intervention arm or control arm. In the intervention arm patients will receive IBD-MAID (IBD modified anti-inflammatory diet) meals for lunch and dinner and advised on appropriate breakfast and snack options by the dietitian at a 1 hour face to face appointment. All meals provided and breakfast/snack options/recipes will align with IBD MAID guidelines (contain no artificial sweeteners, emulsifiers, cured/processed meats and must combine to meet the daily targets of pro-inflammatory diet constituents such as extra virgin olive oil, fruits, vegetables and wholegrains daily). Participants in the control group will see the dietitian face to face for a 1 hour appointment for general dietary advice (GDA) and be provided with recipes from the eat for health national campaign for the 8 week period. Baseline measures will be repeated at week 8 and participants will have a 1 week washout period before being crossed over to the intervention arm. After the 8 week intervention period all participants will be invited to continue following the IBD MAID diet for a further 10 months. Consenting participants will receive further IBD MAID education and counselling from the dietitian at the 8 week follow up 30-45 minute face to face appointment. Participants will have the contact details of the dietitian for support during the intervention period. The dietitian will also send participants new recipes monthly during the 10 month period and participants will be contacted monthly by the dietitian via telehealth or phone (~10 mins) to provide additional dietary support and guidance. IBD MAID dietary adherence will be assessed by an online 3 day food diary completed monthly and checklist of key dietary nutrients completed weekly.
Query!
Intervention code [1]
315693
0
Treatment: Other
Query!
Intervention code [2]
315862
0
Lifestyle
Query!
Comparator / control treatment
The general healthy eating (GHE) group receives dietitian education and a written resource on general healthy eating with IBD. A booklet of healthy recipes obtained from the ‘Eat for Health,’ national campaign will also be provided.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
321556
0
Disease activity assessed via the Simple Clinical Colitis Activity Index (SCCAI) score for participants with UC.
Query!
Assessment method [1]
321556
0
Query!
Timepoint [1]
321556
0
8 weeks post intervention commencement.
Query!
Primary outcome [2]
321819
0
Disease activity assessed via the Crohn’s Disease Activity Index (CDAI) score for participants with CD.
Query!
Assessment method [2]
321819
0
Query!
Timepoint [2]
321819
0
8 weeks post intervention commencement
Query!
Secondary outcome [1]
375349
0
Dietary intake composition: 3-day diet diary completed online analysed on Foodworks Xyris version 9
Query!
Assessment method [1]
375349
0
Query!
Timepoint [1]
375349
0
8 weeks post intervention commencement.
Query!
Secondary outcome [2]
375724
0
Inflammatory marker: C-reactive protein (CRP)
Obtained via blood sample.
Query!
Assessment method [2]
375724
0
Query!
Timepoint [2]
375724
0
8 weeks post intervention commencement
Query!
Secondary outcome [3]
375725
0
Patient reported outcomes (PROs); stool frequency, rectal bleeding and abdominal pain
Assessed on a 5 point likert scale.
Query!
Assessment method [3]
375725
0
Query!
Timepoint [3]
375725
0
8 weeks post intervention commencement
Query!
Secondary outcome [4]
375726
0
Microbiota profile changes post diet implementation via 16S rRNA gene (a phylogenetics marker present in all bacteria) sequencing.of a stool sample.
Query!
Assessment method [4]
375726
0
Query!
Timepoint [4]
375726
0
8 weeks post intervention commencement
Query!
Secondary outcome [5]
375727
0
Attrition rates
Query!
Assessment method [5]
375727
0
Query!
Timepoint [5]
375727
0
8 weeks post intervention commencement.
Query!
Secondary outcome [6]
375728
0
Endoscopic changes indicating mucosal healing assessed via flexible sigmoidoscopy or endoscopy.
Query!
Assessment method [6]
375728
0
Query!
Timepoint [6]
375728
0
8 weeks post intervention commencement.
Query!
Secondary outcome [7]
375730
0
Percentage of UC patients maintaining clinical improvements in SCCAI after adhering to the IBD modified anti-inflammatory diet for 12 months
Query!
Assessment method [7]
375730
0
Query!
Timepoint [7]
375730
0
12 months post intervention commencement
Query!
Secondary outcome [8]
376102
0
Inflammatory marker: faecal calprotectin (FC)
Obtained from a stool sample
Query!
Assessment method [8]
376102
0
Query!
Timepoint [8]
376102
0
8 weeks post intervention commencement
Query!
Secondary outcome [9]
376103
0
IBD Quality of life score (PRO).
Assessed vis the 'Short Inflammatory Bowel Disease Questionnaire'(SIBDQ) is a 10 item shortened version of the
original IBDQ which was 32 items. Measures quality of life as measured in four domains, bowel
symptoms, emotional health, systemic systems and social function.
Query!
Assessment method [9]
376103
0
Query!
Timepoint [9]
376103
0
8 weeks post intervention commencement
Query!
Secondary outcome [10]
376344
0
Checklist of key dietary ingredients
Query!
Assessment method [10]
376344
0
Query!
Timepoint [10]
376344
0
Weekly for 8 weeks post intervention commencement.
Query!
Secondary outcome [11]
376345
0
Percentage of CD patients maintaining clinical improvements in CDAI after adhering to the IBD modified anti-inflammatory diet for 12 months
Query!
Assessment method [11]
376345
0
Query!
Timepoint [11]
376345
0
12 months post intervention commencement
Query!
Eligibility
Key inclusion criteria
Diagnosis of UC or CD established for at least 3 months prior to time of consent
Mild to moderate disease activity at time of consent
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
- Become pregnant or are currently pregnant or lactating
- Current smokers or individuals who have ceased smoking within12 months prior to screening
- Excessive ETOH consumption as defined as >2glasses per day
- Multiple food allergies/intolerances which may affect ability to follow the diet prescription.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Other
Query!
Other design features
The control group crosses over to the intervention group (participants in the intervention group who consent continue following the IBD MAID diet for a further 10 months i.e. do not cross over to control group).
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
6/01/2020
Query!
Actual
25/09/2020
Query!
Date of last participant enrolment
Anticipated
30/08/2021
Query!
Actual
Query!
Date of last data collection
Anticipated
28/02/2022
Query!
Actual
Query!
Sample size
Target
50
Query!
Accrual to date
5
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
QLD
Query!
Recruitment hospital [1]
19295
0
Royal Brisbane & Womens Hospital - Herston
Query!
Recruitment postcode(s) [1]
33878
0
4029 - Herston
Query!
Funding & Sponsors
Funding source category [1]
303951
0
University
Query!
Name [1]
303951
0
The University of Queensland
Query!
Address [1]
303951
0
Human Movement and Nutrition Sciences
Building 26B
St Lucia, Queensland, Australia 4067
Query!
Country [1]
303951
0
Australia
Query!
Primary sponsor type
University
Query!
Name
The University of Queensland
Query!
Address
Human Movement and Nutrition Sciences
Building 26B
St Lucia, Queensland, Australia 4067
Query!
Country
Australia
Query!
Secondary sponsor category [1]
304109
0
None
Query!
Name [1]
304109
0
Query!
Address [1]
304109
0
Query!
Country [1]
304109
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
304451
0
Metro North Hospital and Health Service
Query!
Ethics committee address [1]
304451
0
Lower ground floor, Executive Offices James Mayne Building Butterfield Street HERSTON QLD 4029
Query!
Ethics committee country [1]
304451
0
Australia
Query!
Date submitted for ethics approval [1]
304451
0
30/09/2019
Query!
Approval date [1]
304451
0
03/03/2020
Query!
Ethics approval number [1]
304451
0
Query!
Summary
Brief summary
The aim of this study is to investigate the safety, feasibility and efficacy of an anti-inflammatory diet prescription to dampening inflammatory pathways, in conjunction with standard medical therapy, on disease activity, and the gut microbiota composition in individuals with mild to moderate disease.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
96990
0
Ms Abigail Marsh
Query!
Address
96990
0
Department of Nutrition and Dietetics
Royal Brisbane and Women’s Hospital
Butterfield St
Herston, Queensland, Australia 4006
Query!
Country
96990
0
Australia
Query!
Phone
96990
0
+61 7 36460544
Query!
Fax
96990
0
Query!
Email
96990
0
[email protected]
Query!
Contact person for public queries
Name
96991
0
Abigail Marsh
Query!
Address
96991
0
Department of Nutrition and Dietetics
Royal Brisbane and Women’s Hospital
Butterfield St
Herston, Queensland, Australia 4006
Query!
Country
96991
0
Australia
Query!
Phone
96991
0
+61 7 36460544
Query!
Fax
96991
0
Query!
Email
96991
0
[email protected]
Query!
Contact person for scientific queries
Name
96992
0
Abigail Marsh
Query!
Address
96992
0
Department of Nutrition and Dietetics
Royal Brisbane and Women’s Hospital
Butterfield St
Herston, Queensland, Australia 4006
Query!
Country
96992
0
Australia
Query!
Phone
96992
0
+61 7 36460544
Query!
Fax
96992
0
Query!
Email
96992
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF